The pharmaceutical industry won approval to market a record number of new drugs for rare diseases last year, as a combination of scientific innovation and business opportunity spurred new treatments for diseases long-ignored by drug companies. Many of these so-called orphan drugs offer extra patent protections and faster government approval.
Kodak is at a crossroads: It could go the way of Circuit City, or it could prosper after bankruptcy like General Motors. Even in bankruptcy, the company boasts some enviable strengths, including a rich collection of photo patents, and more than $4 billion in annual sales. But it may be too late for a transition.
American Auto-Matrix announced that it resolved its patent infringement lawsuit against TSI Inc. with an amicable and mutually beneficial settlement. The lawsuit, which had been pending in federal court since May 17, 2010, involved AMM’s U.S. Patent number 5,764,579, entitled “System for Controlling Laboratories with Fume Hoods”.
An R&D 100 Award-winning technology from National Renewable Energy Laboratory has recently been licensed to Natcore, a Colorado-based company that is able to commercialize the “black silicon” technology with its liquid phase deposition process.
The 100 top innovators have been ranked this week by the Thomson Reuters’ intellectual property (IP) consulting arm. The U.S. continues to lead this list with a large share of innovators, and Asia and Europe place second and third, respectively. However, China is not yet ranked because of its practices regarding protecting IP and commercializing products globally.
Patents have become highly valuable to digital device makers who want to protect themselves from intellectual property lawsuits, and Kodak, which is facing the worst crisis of its 131-year history, is banking on this trend to save itself from ruin.
Among the many revelations from Walter Isaacson’s biography of Apple’s co-founder is the anger Jobs had toward Google, which he claimed stole technology and features from Apple for its Android software. His comments suggest Google, which has been acquiring patents to shore up its legal claims, may face vigorous court battles with Apple.
A new set of agreements between magnetic memory developer Crocus and IBM will provide mutual access to patents that will enable the companies to collaborate and integrate magnetic technology into semiconductor products.
Technology firms frequently require workers to sign non-compete agreements, which typically bar their employees from joining rival companies for one to two years. A new study of more than 1,000 engineers, conducted by an MIT professor, shows that these agreements come with a high cost for employees.
President Barack Obama signed into law Friday a major overhaul of the U.S. patent system, a measure designed to ease the way for inventors to bring their products to market. Passed in a rare display of congressional bipartisanship, the America Invents Act is the first significant change in patent law since 1952. It has been hailed as a milestone that would spur innovation and create jobs.
Ziptronix Inc. has signed a licensing agreement with Sony Corporation for the use of Ziptronix's patents regarding oxide bonding technology for backside illumination imaging sensors.
A federal court said Friday that human genes can be patented, reversing a lower court's ruling that involved a test for breast cancer but which could have had big implications for biotechnology and pharmaceutical companies.
After losing out to a consortium of technology companies during bidding for thousands of patents from the bankrupt Nortel, Google has bolstered its war chest with a collection of patents from IBM, one of the industry’s leading generators of intellectual property. The move has less to do with innovation than it does an effort to defend against lawsuits from other tech companies.
The next 14 months will bring generic versions of seven of the world's 20 best-selling drugs, including the top two: cholesterol fighter Lipitor and blood thinner Plavix. Generic competition will decimate sales of the brand-name drugs and cut costs to patients and companies that provide health benefits.
NASA often gets criticized for not living up to the hype when it comes to generating everyday technologies. Tang, to take the oft-cited example, was used by NASA, but not invented by the Apollo program. But defenders point to evidence that Space Shuttle program has prompted innovation that could have occurred in no other way.
A consortium that includes a veritable who’s-who of telecommunications and software giants have successfully placed their $4.5 billion cash bid for thousands of patents held by bankrupt telecom-equipment maker Nortel Networks Corp. The patents cover technologies that include data networking, semiconductors and 4G wireless systems. Nortel won three R&D 100 Awards for its products in the late 1990s and early 2000s.
The U.S. International Trade Commission in Washington is expected to issue a ruling Thursday on Kodak's complaint that its 2001 image-preview patent was infringed by iPhone behemoth Apple Inc., of Cupertino, California, and Research in Motion, maker of the BlackBerry. The embattled company is hoping to negotiate a licensing deal for the technology worth $1 billion.
Do scientists' job locations have any impact on the way their work spreads? According to a study co-authored by an MIT economist, yes, it does, even in the Internet age. Frequent job and location switches, for example, can increase citation frequency for published works. But what happens with patents is entirely different.
A patent battle between two technology heavyweights, Huawei Technologies and ZTE Corp., has entered court as they try to stake their territory in the European mobile phone market. The dispute centers on alleged patent infringement by ZTE on Huawei’s fourth-generation mobile technology. At stake are billions of dollars in future sales.
IBM and Samsung Electronics Co. announced this week they have signed a patent cross-license agreement, which means each will license its respective patent portfolios to the other. In 2010, IBM was the top producer of new patents in the U.S., while South Korea's Samsung was also among the top 10.
Cures for paralysis, blindness and diabetes could all be in reach with embryonic stem cell research, but the pursuit of medical progress is being choked by the U.S. rush to secure patents, experts say.
2010 patent grants hit an all-time high, 31% over 2009. Once again, IBM tops the list as the first company to break 5,000 patents in a single year, and it did so handily. Other notable filers include Apple, Qualcomm, NEC, and SAP, all of which saw 70+% gains in patents this year.
Patent valuation is one of the trickiest tasks a company can face, according to patent law expert David Wanetick with The Business Development Academy, who has written a primer on how valuation—and vulnerability—can affected by many factors.
Private funding for technology maturation will help enable better commercialization of governmental scientific research. However compelling the technology, a gap often exists between government-funded research and its transfer to the marketplace. As a research project nears completion, federal dollars often dry up before an invention has progressed enough to spin out as a commercial product. Enter technology maturation funds, the means by which many promising technologies make needed advances toward becoming commercial products.
- Page 2